You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百克生物(688276.SH):2024年度淨利潤同比下降52.31%
格隆匯 02-25 15:48

格隆匯2月25日丨百克生物(688276.SH)公佈2024年度業績快報,報告期內,公司營業總收入12.29億元,同比下降32.64%;歸屬於母公司所有者的淨利潤2.39億元,同比下降52.31%;歸屬於母公司所有者的扣除非經常性損益的淨利潤2.37億元,同比下降52.06%。

2024年度業績變動主要受民衆疫苗接種意願降低、市場需求減少等因素影響,公司帶狀皰疹減毒活疫苗銷售、使用受到較大影響,導致接種、發貨數量下降,營業總收入及淨利潤同比下滑。應對以上不利因素,公司將持續優化市場營銷體系,加大科普宣教投入力度,通過官媒、新媒體等宣傳途徑,努力提升公衆對相關疾病的認知度,激發用戶需求。同時,優化數字化營銷模式,實現線上、線下覆蓋,提升產品的市場佔有率,提高公司核心競爭力和行業認可度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account